Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury
- 14 June 2010
- journal article
- research article
- Published by Taylor & Francis in Brain Injury
- Vol. 24 (7-8) , 959-969
Abstract
Objectives: To determine which serotonergic system-related single nucleotide polymorphisms (SNPs) predicted variation in treatment response to citalopram in depression following a traumatic brain injury (TBI). Methods: Ninety (50 M/40 F, aged 39.9, SD = 18.0 years) post-TBI patients with a major depressive episode (MDE) were recruited into a 6-week open-label study of citalopram (20 mg/day). Six functional SNPs in genes related to the serotonergic system were examined: serotonin transporter (5HTTLPR including rs25531), 5HT1A C-(1019)G and 5HT2A T-(102)C, methylene tetrahydrofolate reductase (MTHFR) C-(677)T, brain-derived neurotrophic factor (BDNF) val66met and tryptophan hydroxylase-2 (TPH2) G-(703)T. Regression analyses were performed using the six SNPs as independent variables: Model 1 with response (percentage Hamilton Depression (HAMD) change from baseline to endpoint) as the dependent variable and Model 2 with adverse event index as the dependent variable (Bonferroni corrected p-value < 0.025). Results: MTHFR and BDNF SNPs predicted greater treatment response (R2= 0.098, F = 4.65, p = 0.013). The 5HTTLPR predicted greater occurrence of adverse events (R2= 0.069, F = 5.72, p = 0.020). Conclusion: Results suggest that polymorphisms in genes related to the serotonergic system may help predict short-term response to citalopram and tolerability to the medication in patients with MDE following a TBI.Keywords
This publication has 81 references indexed in Scilit:
- A Genomewide Association Study of Citalopram Response in Major Depressive DisorderBiological Psychiatry, 2010
- Interaction Between the Serotonin Transporter Gene (5-HTTLPR), Stressful Life Events, and Risk of DepressionJAMA, 2009
- Major depressive disorder is associated with attenuated cardiovascular reactivity and impaired recovery among those free of cardiovascular disease.Health Psychology, 2009
- 5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depressionNeuroscience Letters, 2008
- The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-AmericansNeuroReport, 2007
- Serotonin transporter function, but not expression, is dependent on brain‐derived neurotrophic factor (BDNF): in vivo studies in BDNF‐deficient miceJournal of Neurochemistry, 2006
- Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related BehaviorScience, 2006
- Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive DisorderThe American Journal of Human Genetics, 2006
- Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531Molecular Psychiatry, 2006
- Homovanillic Acid and 5-Hydroxyindole-Acetic Acid in the CSF of Patients after a Severe Head InjuryEuropean Neurology, 1975